DSpace Repository
Prevalence of some PIK3CA mutations in patients with cervical Squamous Carcinoma from the Republic of Moldova
JavaScript is disabled for your browser. Some features of this site may not work without it.
| dc.contributor.author | POPA, Cristina | |
| dc.contributor.author | STRATAN, Valentina | |
| dc.contributor.author | TUTUIANU, Valeri | |
| dc.contributor.author | SITNIC, Victor | |
| dc.contributor.author | BALAN, Veronica | |
| dc.contributor.author | NOVAC, Mihail | |
| dc.contributor.author | SPRINCEAN, Mariana | |
| dc.contributor.author | CASIAN, Neonila | |
| dc.date.accessioned | 2024-04-25T07:39:44Z | |
| dc.date.available | 2024-04-25T07:39:44Z | |
| dc.date.issued | 2024 | |
| dc.identifier.citation | POPA, Cristina et al. Prevalence of some PIK3CA mutations in patients with cervical Squamous Carcinoma from the Republic of Moldova. In: Quo Vadis – Ethics of the Scientific Research: conf. NANO-2024, event devoted to the 60th anniversary of the Technical University of Moldova, 15-18 April 2024, Chişinău, Republica Moldova: Program and proceedings of the conference, Chişinău 2024, pp. 59-60. ISBN 978-9975-64-422-8. | en_US |
| dc.identifier.isbn | 978-9975-64-422-8 | |
| dc.identifier.uri | http://repository.utm.md/handle/5014/26905 | |
| dc.description.abstract | The study aimed to determine the prevalence of mutations in the PIK3CA gene in a cohort of CSCC patients from the Republic of Moldova. The tested prevalence of the PIK3CA mutations was 29.35%. Testing revealed that 25 patients were positive for a single mutation, and two tested positive for a double mutation. Since many patients have these mutations, there is a chance that CSCC patients from the Republic of Moldova will benefit from the development of anti-PI3K targeted therapy. | en_US |
| dc.language.iso | en | en_US |
| dc.publisher | Technical University of Moldova | en_US |
| dc.relation.ispartofseries | NANO-2024 "Quo Vadis – Ethics of the Scientific Research", event devoted to the 60th anniversary of the Technical University of Moldova;15-18 April 2024, Chişinău, Republica Moldova | |
| dc.rights | Attribution-NonCommercial-NoDerivs 3.0 United States | * |
| dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/3.0/us/ | * |
| dc.subject | cervical squamous cell carcinoma | en_US |
| dc.subject | targeted therapy | en_US |
| dc.title | Prevalence of some PIK3CA mutations in patients with cervical Squamous Carcinoma from the Republic of Moldova | en_US |
| dc.type | Article | en_US |
Files in this item
The following license files are associated with this item:
This item appears in the following Collection(s)
Except where otherwise noted, this item's license is described as Attribution-NonCommercial-NoDerivs 3.0 United States